文献速递心血管CT

冠状动脉钙化与冠状动脉疾病自然史的关系

The Relationship Between Coronary Calcification and the Natural History of Coronary Artery Disease.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-11-18

基于PARADIGM注册中925例患者2568个病灶的连续冠状动脉CT血管成像,分析钙化斑块体积(CPV)和钙化斑块体积百分比(PCPV)与斑块进展及主要不良心脏事件的关系。CPV与总斑块负荷强相关,校正斑块体积后关联反转;PCPV独立预测斑块体积缩小,患者水平高CPV与主要不良心脏事件相关(HR 3.01),高PCPV则呈反向关联(HR 0.529)。

要点

  • 钙化斑块体积与总斑块负荷强相关,是风险与疾病进展的标志。
  • 钙化斑块体积占斑块总体积的百分比(PCPV)升高提示斑块稳定、风险降低。
  • 患者水平高CPV与主要不良心脏事件相关,高PCPV则呈反向关联。

核心结论

  • 钙化斑块因与总斑块负荷强相关而成为不良事件与疾病进展风险的标志。
  • 以占总斑块体积百分比表示时,PCPV升高是病灶水平和患者水平斑块稳定与风险降低的标志。

研究设计与样本

  • 来自PARADIGM注册的分析,纳入925例患者共2568个病灶,患者均接受临床指征的连续冠状动脉CT血管成像。
  • 在病灶水平和患者水平(所有单个病灶之和)计算CPV及PCPV,PCPV=(CPV/斑块体积)×100。

关键影像表现/征象

  • 基线时CPV与斑块体积强相关(r=0.780;p<0.001),并与斑块进展相关(r=0.297;p<0.001)。
  • 校正基线斑块体积后,CPV与斑块进展的关联反转(r=-0.146;p<0.001)。
  • PCPV在单变量和多变量线性回归分析中均为斑块体积缩小的独立预测因子(r=-0.11;p<0.001)。

诊断标准与关键数值

  • 患者水平分析显示,高CPV与主要不良心脏事件相关(风险比3.01;95%CI 1.58至5.72)。
  • 多变量分析显示,高PCPV与主要不良心脏事件呈反向关联(风险比0.529;95%CI 0.229至0.968)。

临床应用与阅片要点

  • 阅片时除报告钙化斑块绝对体积外,可关注钙化斑块体积占斑块总体积的百分比。
  • 高CPV提示总斑块负荷大、不良事件风险高;高PCPV提示斑块稳定、风险降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of the current study was to explore the impact of plaque calcification in terms of absolute calcified plaque volume (CPV) and in the context of its percentage of the total plaque volume at a lesion and patient level on the progression of coronary artery disease.

BACKGROUND: Coronary artery calcification is an established marker of risk of future cardiovascular events. Despite this, plaque calcification is also considered a marker of plaque stability, and it increases in response to medical therapy.

METHODS: This analysis included 925 patients with 2,568 lesions from the PARADIGM (Progression of Atherosclerotic Plaque Determined by Computed Tomographic Angiography Imaging) registry, in which patients underwent clinically indicated serial coronary computed tomography angiography. Plaque calcification was examined by using CPV and percent CPV (PCPV), calculated as (CPV/plaque volume) × 100 at a per-plaque and per-patient level (summation of all individual plaques).

RESULTS: CPV was strongly correlated with plaque volume (r = 0.780; p < 0.001) at baseline and with plaque progression (r = 0.297; p < 0.001); however, this association was reversed after accounting for plaque volume at baseline (r = -0.146; p < 0.001). In contrast, PCPV was an independent predictor of a reduction in plaque volume (r = -0.11; p < 0.001) in univariable and multivariable linear regression analyses. Patient-level analysis showed that high CPV was associated with incident major adverse cardiac events (hazard ratio: 3.01: 95% confidence interval: 1.58 to 5.72), whereas high PCPV was inversely associated with major adverse cardiac events (hazard ratio: 0.529; 95% confidence interval: 0.229 to 0.968) in multivariable analysis.

CONCLUSIONS: Calcified plaque is a marker for risk of adverse events and disease progression due to its strong association with the total plaque burden. When considered as a percentage of the total plaque volume, increasing PCPV is a marker of plaque stability and reduced risk at both a lesion and patient level. (Progression of Atherosclerotic Plaque Determined by Computed Tomographic Angiography Imaging [PARADIGM]; NCT02803411).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Jin HY, Weir-McCall JR, Leipsic JA, et al. The Relationship Between Coronary Calcification and the Natural History of Coronary Artery Disease. JACC Cardiovasc Imaging. 2020. PMID: 33221216. doi:10.1016/j.jcmg.2020.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。